All Recalls

95,018 total recalls in our database

CGMP Deviations: recalling drug products following an FDA inspection.

Feb 7, 2023 Prescription Drugs View Details →

Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Feb 13, 2023 Prescription Drugs Nationwide View Details →

CGMP Deviations: recalling drug products following an FDA inspection.

Feb 7, 2023 Prescription Drugs View Details →